cefixime has been researched along with Bacterial Disease in 51 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections." | 9.08 | [A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections]. ( Hao, F; Li, J; Zhao, C, 1997) |
| "Cefixime was compared with amoxicillin for treatment of acute otitis media in a randomized trial." | 9.07 | Cefixime compared with amoxicillin for treatment of acute otitis media. ( Carlin, SA; Christopher, NC; Johnson, CE; Rehmus, JM; Roberts, DG; Shurin, PA; Super, DM; Whitwell, JK, 1991) |
| "Sixty patients with lower respiratory tract infections, mainly acute bronchitis were treated for 14 days with either cefixime 200 mg twice daily (plus placebo once daily) or amoxicillin/clavulanic acid 500 mg/125 mg thrice daily in a double-blind manner." | 9.06 | Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections. ( Beumer, HM, 1989) |
| "Cefixime (CFIX) was administered 200 mg (2 divided doses) per day to 154 female patients with acute uncomplicated cystitis." | 9.06 | [Clinical evaluation of cefixime in the treatment of acute uncomplicated cystitis]. ( Arakawa, M; Asano, Y; Gotoh, T; Imanaka, K; Kakizaki, H; Koyanagi, T; Kubota, M; Nagamori, S; Nonomura, K; Togashi, M, 1989) |
| "Cefprozil was evaluated in the treatment of acute otitis media with effusion in three open, randomized, multicenter comparative clinical trials." | 7.77 | Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media. ( Kafetzis, DA, 1994) |
| "Cefixime (CFIX, Cefspan), a new oral cephem, was used in the treatment of urinary tract infections, and was evaluated for its therapeutic effectiveness and safety at the Department of Urology, Osaka Rosai Hospital." | 7.67 | [Clinical experience with cefixime in urinary tract infections]. ( Iwao, N; Kameoka, H; Miyoshi, S; Mizutani, S; Takano, Y, 1989) |
| "Cefixime was administered for five to twelve days twice daily in a dose of 200 mg." | 6.67 | [Cefixime treatment in different bacterial infections in the ENT region]. ( Benner, U; Blessing, R; Pelz, K; Schlenter, WW, 1990) |
| "Cefixime was effective in the treatment of bacterial sinus infections in adults and was well tolerated." | 6.67 | Evaluation of cefixime in the treatment of bacterial maxillary sinusitis. ( Edelstein, DR; Kimmelman, CP; Kohlbrenner, VM; Kohut, RI; Marinaccio, AT; Matthews, BL; McCaffrey, TV; Parnes, SM; Rapp, M; Rybak, LP, 1993) |
| " The antibiotic was given at a dosage of 200 mg b." | 6.67 | [Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract]. ( Kersten, W; Müsken, H, 1990) |
| "Cefixime is a third-generation oral cephalosporin that is highly active against a broad range of gram-negative and some gram-positive aerobic bacteria." | 6.41 | Cefixime in urinary tract infections with special reference to pediatrics: overview. ( Cataldi, L; Fanos, V, 2001) |
| " One child developed bacteremia 3 days after completing the course of cefixime, and one had splenic sequestration on the fourth study day." | 5.08 | Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease. ( Dancy, RM; Day, SW; Harris, SC; Wang, WC; Wilimas, JA; Williams, LL, 1996) |
| "A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections." | 5.08 | [A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections]. ( Hao, F; Li, J; Zhao, C, 1997) |
| "Cefixime was compared with amoxicillin for treatment of acute otitis media in a randomized trial." | 5.07 | Cefixime compared with amoxicillin for treatment of acute otitis media. ( Carlin, SA; Christopher, NC; Johnson, CE; Rehmus, JM; Roberts, DG; Shurin, PA; Super, DM; Whitwell, JK, 1991) |
| "Sixty patients with lower respiratory tract infections, mainly acute bronchitis were treated for 14 days with either cefixime 200 mg twice daily (plus placebo once daily) or amoxicillin/clavulanic acid 500 mg/125 mg thrice daily in a double-blind manner." | 5.06 | Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections. ( Beumer, HM, 1989) |
| "Cefixime (CFIX) was administered 200 mg (2 divided doses) per day to 154 female patients with acute uncomplicated cystitis." | 5.06 | [Clinical evaluation of cefixime in the treatment of acute uncomplicated cystitis]. ( Arakawa, M; Asano, Y; Gotoh, T; Imanaka, K; Kakizaki, H; Koyanagi, T; Kubota, M; Nagamori, S; Nonomura, K; Togashi, M, 1989) |
| "Cefprozil was evaluated in the treatment of acute otitis media with effusion in three open, randomized, multicenter comparative clinical trials." | 3.77 | Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media. ( Kafetzis, DA, 1994) |
| "Cefixime (CFIX, Cefspan), a new oral cephem, was used in the treatment of urinary tract infections, and was evaluated for its therapeutic effectiveness and safety at the Department of Urology, Osaka Rosai Hospital." | 3.67 | [Clinical experience with cefixime in urinary tract infections]. ( Iwao, N; Kameoka, H; Miyoshi, S; Mizutani, S; Takano, Y, 1989) |
| "The therapeutic activity of FCE 22891 was compared with that of two new oral cephalosporins, cefuroxime axetil and cefixime against Streptococcus pneumoniae respiratory infection and subcutaneous abscesses induced by mixed aerobes and anaerobes in mice." | 3.67 | Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice. ( Castellani, P; Della Bruna, C; Rossi, R; Younes, G, 1989) |
| "The absorption and excretion and clinical effectiveness of cefixime (CFIX) granules, a new oral cephalosporin, were studied with pediatric patients with tonsillitis and urinary tract infection (UTI)." | 3.67 | [Clinical study on cefixime granules in the field of pediatrics]. ( Haruta, T; Kobayashi, Y; Kuroki, S, 1986) |
| "Cefixime (CFIX) was given orally to 25 children with acute bacterial infections including 13 with acute tonsillitis, 1 with acute tonsillitis and cervical lymphadenitis, 1 with acute bronchitis, 5 with bronchopneumonia and 5 with urinary tract infection." | 3.67 | [Clinical experience with cefixime in the pediatric field]. ( Aihara, R; Kobashi, H; Nishioka, A; Ohara, K; Okamoto, T, 1986) |
| "A clinical study of cefixime (CFIX), a new oral cephalosporin, was carried out to evaluate its therapeutic effectiveness on bacterial infections in children." | 3.67 | [Clinical studies on cefixime in pediatrics]. ( Endo, S; Hosoda, T; Masuda, M; Mimoto, H; Miyao, M; Tanaka, H; Yuasa, Y, 1986) |
| "Cefixime was effective in the treatment of bacterial sinus infections in adults and was well tolerated." | 2.67 | Evaluation of cefixime in the treatment of bacterial maxillary sinusitis. ( Edelstein, DR; Kimmelman, CP; Kohlbrenner, VM; Kohut, RI; Marinaccio, AT; Matthews, BL; McCaffrey, TV; Parnes, SM; Rapp, M; Rybak, LP, 1993) |
| "Bacteriological, pharmacokinetic and clinical studies on cefdinir (CFDN, FK482), a new oral cephalosporin, 5% and 10% granules, were performed in the field of pediatrics." | 2.67 | [Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field]. ( Hatakeyama, K; Hori, M; Nakano, K; Sakaguchi, N; Sugita, M; Toyonaga, Y; Yamazaki, M; Yamori, K, 1992) |
| " The antibiotic was given at a dosage of 200 mg b." | 2.67 | [Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract]. ( Kersten, W; Müsken, H, 1990) |
| "Cefixime was administered for five to twelve days twice daily in a dose of 200 mg." | 2.67 | [Cefixime treatment in different bacterial infections in the ENT region]. ( Benner, U; Blessing, R; Pelz, K; Schlenter, WW, 1990) |
| "Cefixime is an example of the latter." | 2.66 | [Cefixime, the first oral third-generation cephalosporin]. ( Roche, G, 1989) |
| "Cefixime is a third-generation oral cephalosporin that is highly active against a broad range of gram-negative and some gram-positive aerobic bacteria." | 2.41 | Cefixime in urinary tract infections with special reference to pediatrics: overview. ( Cataldi, L; Fanos, V, 2001) |
| "Cefixime is a new orally active third-generation cephalosporin with a broad spectrum of activity against a variety of both gram-positive and -negative bacteria including many beta-lactamase-producing strains of streptococci, Haemophilus influenzae, Neisseria gonorrhoeae, and the majority of the Enterobacteriaceae." | 2.38 | Cefixime. ( Caravaggio, C; Leggett, NJ; Rybak, MJ, 1990) |
| "Cefixime has little activity against Staphylococcus aureus and is inactive against Pseudomonas aeruginosa." | 2.38 | Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential. ( Brogden, RN; Campoli-Richards, DM, 1989) |
| " Simulations based on this model allow the comparison of antibacterial efficacy of different antibiotics and dosing regimens." | 1.33 | Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models. ( Derendorf, H; Liu, P; Obermann, B; Rand, KH, 2005) |
| "The cefixime preparation was also significantly the least likely to be selected as the worst-tasting preparation (2 [10%], P<." | 1.31 | Palatability of oral antibiotics among children in an urban primary care center. ( Angelilli, ML; Matsui, DM; Rieder, MJ; Toscani, M, 2000) |
| "Cefixime is a new oral cephalosporin with in vitro activity similar to that of third-generation cephalosporins." | 1.28 | [Biliary excretion and hepatic disposal of cefixime: experimental and clinical study]. ( Blickle, JF; Brogard, JM; Dorner, M; Jehl, F; Monteil, H; Westphal, JF, 1992) |
| "Twenty-one pediatric patients with bacterial infections (10, tonsillitis; 4, pharyngitis; and 7, urinary tract infections) were treated with CFIX at doses of 1." | 1.27 | [Fundamental and clinical studies on cefixime in the pediatric field]. ( Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, S; Nakashima, T, 1986) |
| "70 microgram/ml for a 3 mg/kg dosage and 2." | 1.27 | [Fundamental and clinical studies on cefixime in pediatrics]. ( Iwai, N; Katayama, M; Mizoguchi, F; Nakamura, H; Shibata, M, 1986) |
| "86 hours and urinary excretions rates up to 12 hours after dosing were 16." | 1.27 | [Clinical studies of cefixime granules in pediatrics]. ( Chikaoka, H; Kamigaki, M; Koido, R; Matsumoto, K; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H, 1986) |
| "Cefixime (CFIX) was evaluated for pharmacokinetics, therapeutic effectiveness on infection, safety, and bacteriological effectiveness in pediatrics." | 1.27 | [Fundamental and clinical studies on cefixime in pediatric field]. ( Kida, K; Matsuda, H; Miyazaki, M; Murase, M, 1986) |
| " The mean half-life and the mean AUC values were 2." | 1.27 | [Pharmacokinetics and clinical effects of cefixime in pediatrics]. ( Ishimoto, K; Koga, T; Motohiro, T; Nagayama, K; Nishiyama, T; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, S; Yamashita, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (49.02) | 18.7374 |
| 1990's | 21 (41.18) | 18.2507 |
| 2000's | 5 (9.80) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, SS | 1 |
| Woo, SH | 1 |
| Hyun, JH | 1 |
| Choi, HY | 1 |
| Chai, SE | 1 |
| Liu, P | 1 |
| Rand, KH | 1 |
| Obermann, B | 1 |
| Derendorf, H | 1 |
| Goto, S | 2 |
| Fabius, GT | 1 |
| Niël-Weise, B | 1 |
| Jeronimus, A | 1 |
| Girmenia, C | 1 |
| Russo, E | 1 |
| Carmosino, I | 1 |
| Breccia, M | 1 |
| Dragoni, F | 1 |
| Latagliata, R | 1 |
| Mecarocci, S | 1 |
| Morano, SG | 1 |
| Stefanizzi, C | 1 |
| Alimena, G | 1 |
| Kamimura, T | 1 |
| Kojo, H | 1 |
| Matsumoto, Y | 1 |
| Mine, Y | 1 |
| Kuwahara, S | 1 |
| Kafetzis, DA | 1 |
| Parent, M | 1 |
| Rodriguez, WJ | 1 |
| Wiedermann, BL | 1 |
| Edelstein, DR | 2 |
| Avner, SE | 1 |
| Chow, JM | 1 |
| Duerksen, RL | 1 |
| Johnson, J | 1 |
| Ronis, M | 1 |
| Rybak, LP | 2 |
| Bierman, WC | 1 |
| Matthews, BL | 2 |
| Kohlbrenner, VM | 2 |
| Kohut, RI | 1 |
| Rapp, M | 1 |
| McCaffrey, TV | 1 |
| Kimmelman, CP | 1 |
| Parnes, SM | 1 |
| Marinaccio, AT | 1 |
| Long, SS | 1 |
| Low, DE | 1 |
| Williams, LL | 1 |
| Wilimas, JA | 1 |
| Harris, SC | 1 |
| Day, SW | 1 |
| Dancy, RM | 1 |
| Wang, WC | 1 |
| Schatz, BS | 1 |
| Karavokiros, KT | 1 |
| Taeubel, MA | 1 |
| Itokazu, GS | 1 |
| Adam, D | 1 |
| Zhao, C | 1 |
| Li, J | 1 |
| Hao, F | 1 |
| Angelilli, ML | 1 |
| Toscani, M | 1 |
| Matsui, DM | 1 |
| Rieder, MJ | 1 |
| Fanos, V | 1 |
| Cataldi, L | 1 |
| Toyonaga, Y | 2 |
| Hatakeyama, K | 1 |
| Yamori, K | 1 |
| Sakaguchi, N | 1 |
| Nakano, K | 1 |
| Yamazaki, M | 1 |
| Sugita, M | 2 |
| Hori, M | 2 |
| Westphal, JF | 1 |
| Brogard, JM | 1 |
| Jehl, F | 1 |
| Blickle, JF | 1 |
| Dorner, M | 1 |
| Monteil, H | 1 |
| Johnson, CE | 1 |
| Carlin, SA | 1 |
| Super, DM | 1 |
| Rehmus, JM | 1 |
| Roberts, DG | 1 |
| Christopher, NC | 1 |
| Whitwell, JK | 1 |
| Shurin, PA | 1 |
| Leonhardt, L | 1 |
| Kersten, W | 1 |
| Müsken, H | 1 |
| Theopold, M | 1 |
| Benner, U | 2 |
| Bauernfeind, A | 1 |
| Schlenter, WW | 1 |
| Blessing, R | 1 |
| Pelz, K | 1 |
| Leggett, NJ | 1 |
| Caravaggio, C | 1 |
| Rybak, MJ | 1 |
| Chonmaitree, T | 1 |
| Owen, MJ | 1 |
| Howie, VM | 1 |
| Roche, G | 1 |
| Cluzel, R | 1 |
| Kameoka, H | 1 |
| Takano, Y | 1 |
| Miyoshi, S | 1 |
| Iwao, N | 1 |
| Mizutani, S | 1 |
| Beumer, HM | 1 |
| Togashi, M | 1 |
| Kubota, M | 1 |
| Nagamori, S | 1 |
| Asano, Y | 1 |
| Imanaka, K | 1 |
| Gotoh, T | 1 |
| Nonomura, K | 1 |
| Koyanagi, T | 1 |
| Arakawa, M | 1 |
| Kakizaki, H | 1 |
| Brogden, RN | 1 |
| Campoli-Richards, DM | 1 |
| Mikawa, H | 1 |
| Mayumi, M | 1 |
| Akiyama, Y | 1 |
| Ito, S | 1 |
| Watanabe, Y | 1 |
| Kanaoka, H | 1 |
| Takeshita, S | 1 |
| Takahashi, Y | 1 |
| Akiyama, F | 1 |
| Yoshimura, T | 1 |
| Rossi, R | 1 |
| Castellani, P | 1 |
| Younes, G | 1 |
| Della Bruna, C | 1 |
| Lin, SR | 1 |
| Peng, CF | 1 |
| Meguro, H | 1 |
| Arimasu, O | 1 |
| Sohda, H | 1 |
| Yoshida, J | 1 |
| Togasaki, K | 1 |
| Fujii, R | 1 |
| Nakazawa, S | 2 |
| Sato, H | 1 |
| Narita, A | 1 |
| Suzuki, H | 1 |
| Matsumoto, K | 1 |
| Chikaoka, H | 1 |
| Kamigaki, M | 1 |
| Koido, R | 1 |
| Niino, K | 1 |
| Sunakawa, K | 1 |
| Saito, N | 1 |
| Ishizuka, Y | 1 |
| Iwata, S | 1 |
| Kumagai, N | 1 |
| Yokota, T | 1 |
| Asaishi, T | 1 |
| Kusano, S | 1 |
| Sato, Y | 1 |
| Kusumoto, Y | 1 |
| Nakamura, H | 2 |
| Joh, K | 1 |
| Takahashi, T | 1 |
| Kurosu, Y | 1 |
| Nakashima, S | 1 |
| Hayakawa, F | 1 |
| Nakashima, T | 1 |
| Miyachi, Y | 1 |
| Hakamada, S | 1 |
| Kuno, K | 1 |
| Iwai, N | 1 |
| Shibata, M | 1 |
| Mizoguchi, F | 1 |
| Katayama, M | 1 |
| Haruta, T | 1 |
| Kuroki, S | 1 |
| Kobayashi, Y | 1 |
| Aihara, R | 1 |
| Kobashi, H | 1 |
| Nishioka, A | 1 |
| Ohara, K | 1 |
| Okamoto, T | 1 |
| Hosoda, T | 1 |
| Masuda, M | 1 |
| Miyao, M | 1 |
| Mimoto, H | 1 |
| Endo, S | 1 |
| Yuasa, Y | 1 |
| Tanaka, H | 1 |
| Kurashige, T | 1 |
| Morita, H | 1 |
| Araki, K | 1 |
| Ogura, H | 1 |
| Morioka, N | 1 |
| Kitamura, I | 1 |
| Miyazaki, M | 1 |
| Kida, K | 1 |
| Matsuda, H | 1 |
| Murase, M | 1 |
| Motohiro, T | 1 |
| Tanaka, K | 1 |
| Koga, T | 1 |
| Shimada, Y | 1 |
| Tomita, S | 1 |
| Nishiyama, T | 1 |
| Ishimoto, K | 1 |
| Tominaga, K | 1 |
| Yamashita, F | 1 |
| Nagayama, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial to Investigate the Infectious Outcomes of Intrarectal Povidone-iodine Cleansing Plus Formalin Disinfection of Needle Tip During Transrectal Ultrasound Guided Prostate Biopsy[NCT03879486] | 1,257 participants (Actual) | Interventional | 2017-05-31 | Completed | |||
| Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting[NCT02473887] | Phase 1 | 40 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for cefixime and Bacterial Disease
| Article | Year |
|---|---|
Worldwide review: microbiological profile of cefixime.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefixime; Humans; Lacta | 1989 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ba | 1994 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infectio | 1994 |
Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combin | 1993 |
Cefixime.
Topics: Bacteria; Bacterial Infections; Biological Availability; Cefixime; Cefotaxime; Child; Humans; Microb | 1993 |
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime | 1996 |
Cefixime in urinary tract infections with special reference to pediatrics: overview.
Topics: Bacterial Infections; Cefixime; Cephalosporins; Child; Child, Preschool; Humans; Infant; Urinary Tra | 2001 |
Cefixime.
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Humans | 1990 |
Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.
Topics: Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Humans | 1989 |
17 trials available for cefixime and Bacterial Disease
| Article | Year |
|---|---|
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ba | 1994 |
Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combin | 1993 |
Evaluation of cefixime in the treatment of bacterial maxillary sinusitis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria | 1993 |
Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease.
Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Anti-Infective Agents; Bacteremia; Bacterial | 1996 |
[A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections].
Topics: Adolescent; Adult; Bacterial Infections; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Escheric | 1997 |
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; | 1992 |
Cefixime compared with amoxicillin for treatment of acute otitis media.
Topics: Acute Disease; Adolescent; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Pr | 1991 |
[Treatment results using cefixime for bacterial respiratory tract infections].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Female; Humans; Male | 1990 |
[Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Bronchopneu | 1990 |
[Effectiveness and tolerance of cefixime in bacterial infections in the ENT area].
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Cefixime; Cefotaxime; Drug Tolerance; Female; Hu | 1990 |
[Cefixime treatment in different bacterial infections in the ENT region].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Cefixime; Cefotaxime; Drug Tolerance | 1990 |
Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cefixime; Cefotaxime; Child | 1990 |
[Cefixime, the first oral third-generation cephalosporin].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Chemical Phenomena | 1989 |
Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
Topics: Adult; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; C | 1989 |
Cefixime--a new oral cephalospalosin.
Topics: Adult; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Clinical Trials as Topic; Humans | 1989 |
[Clinical evaluation of cefixime in the treatment of acute uncomplicated cystitis].
Topics: Acute Disease; Bacterial Infections; Cefixime; Cefotaxime; Clinical Trials as Topic; Cystitis; Femal | 1989 |
[Clinical studies on cefixime in pediatrics].
Topics: Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Ev | 1989 |
27 other studies available for cefixime and Bacterial Disease
| Article | Year |
|---|---|
Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy.
Topics: Adenocarcinoma; Administration, Oral; Administration, Rectal; Adult; Aged; Aged, 80 and over; Antibi | 2003 |
Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefixime; Cefpodoxime; Ceftizoxime; Culture M | 2005 |
An epidemiological study of three cephalosporins: cefotetan, cefixime and cefpirome.
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotetan; Cefpirome; Cephalosporins; Humans; Microbial Se | 1989 |
Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefixime | 2007 |
In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
Topics: Amoxicillin; Animals; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cefacl | 1984 |
[Initial empiric treatment of pneumonia and the new antibiotics].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxi | 1994 |
Assessment of the use of cefixime for switch therapy.
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Humans; Injections | 1995 |
Overview of the clinical features of cefixime.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Chemistry, Pharmaceutical; Drug Administ | 1998 |
Palatability of oral antibiotics among children in an urban primary care center.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithrom | 2000 |
[Biliary excretion and hepatic disposal of cefixime: experimental and clinical study].
Topics: Administration, Oral; Adult; Animals; Anti-Infective Agents, Urinary; Bacterial Infections; Bile; Bi | 1992 |
Recently introduced products.
Topics: Albuterol; Asthma; Bacterial Infections; Breast Diseases; Carboprost; Cefixime; Cefotaxime; Fatty Ac | 1991 |
[Critical concentrations of cefixime and disc potency].
Topics: Bacterial Infections; Bacteriological Techniques; Cefixime; Cefotaxime; Dose-Response Relationship, | 1989 |
[Clinical experience with cefixime in urinary tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefixime; Cefotaxime; Cystitis; Dr | 1989 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Inf | 1989 |
In vitro antibacterial activity of cefixime.
Topics: Amoxicillin; Ampicillin; Bacteria; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cephalexin; | 1988 |
[Clinical evaluation of cefixime in children].
Topics: Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Haemophilus Infections; | 1986 |
[Clinical studies of cefixime granules in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies of cefixime granules in pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies on cefixime (5% granules) in the pediatric field].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies on cefixime in the pediatric field].
Topics: Acute Disease; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female | 1986 |
[Fundamental and clinical studies on cefixime in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infan | 1986 |
[Clinical study on cefixime granules in the field of pediatrics].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; H | 1986 |
[Clinical experience with cefixime in the pediatric field].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchopneumonia; Cefixime; Cefotaxime; Child; Chil | 1986 |
[Clinical studies on cefixime in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Chemical and Drug Induced Liver Injury; Child; | 1986 |
[Fundamental and clinical studies on cefixime in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; H | 1986 |
[Fundamental and clinical studies on cefixime in pediatric field].
Topics: Acute Disease; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Enteritis; Femal | 1986 |
[Pharmacokinetics and clinical effects of cefixime in pediatrics].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Pre | 1986 |